Sealed lyophilized vials typically maintain potency for 18-24 months at 2-8C
El nuevo frmaco, que se administra en comprimidos, tiene un mecanismo de accin completamente diferente al de los conocidos frmacos basados en GLP-1, como Ozempic, que se administra mediante inyecciones
Its just getting informed.
Its essential to determine that there are no contraindications that would interfere with the safety or effectiveness of the treatment
We were surprised to find there were no major differences in revascularization or in-stent restenosis despite our initial inclination that GLP-1RAs may reduce incidences of these cardiovascular events, said Moses Sghayyer, MD, Tinsley Harrison Internal Medicine resident at the University of Alabama at Birmingham in Birmingham, Ala., and lead author of the study